Activity value 72united states Buyer,Last transaction date:
2026-03-03Address: c/o brandnu laboratories,cheshire, ct 06410-1212,60 fieldstone ct
Overview
Import data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for regeneron pharma inc. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 2 transactions, with a transaction quantity of 142 and a transaction weight of 27699.
YearTransactionsQuantityWeight
20258723123079
2026214227699
Bill of lading data
<
1/15
>
Trade date
2026/03/03
B/L No.
dmalbreb55677
Suppliers
swi frankfurt dc de
Buyers
regeneron pharma inc.
POLs
42157, rotterdam
PODs
4601, new york/newark area, newark, nj
Supply area
Netherlands
Purchas area
United States
Product description
PLASTIC PARTS FOR MEDICINAL SYRINGES / INJECTIONS (WITHOUT NEEDLES AND WITHOUT DRUG) PLASTIC PARTS FOR MEDICINAL SYRINGES / INJECTIONS (WITHOUT NEEDLES AND WITHOUT DRUG) PLASTIC PARTS FOR MEDICINAL SYRINGES / INJECTIONS (WITHOUT NEEDLES AND WITHOUT DRUG) PLASTIC PARTS FOR MEDICINAL SYRINGES / INJECTIONS (WITHOUT NEEDLES AND WITHOUT DRUG) PLASTIC PARTS FOR MEDICINAL SYRINGES / INJECTIONS (WITHOUT NEEDLES AND WITHOUT DRUG) PLASTIC PARTS FOR MEDICINAL SYRINGES / INJECTIONS (WITHOUT NEEDLES AND WITHOUT DRUG) Expand
Trade date
2025/10/12
B/L No.
dmalbreb47418
Suppliers
swi frankfurt dc de
Buyers
regeneron pharma inc.
POLs
42870, bremerhaven
PODs
4601, new york/newark area, newark, nj
Supply area
Netherlands
Purchas area
United States
5exertis
united statesbuyer,they trade on 2021-05-15
10.96%
>
Products
Total 1
ProductsTransactionsPerDetail
pharmaceutical 78100%>
Hscode rank
Total 5
HSCode NameTransactionsPerDetail
HS 9018317596.15%>
HS 30068033.85%>
Trading Area
Total 7
AreaTransactionsPerDetail
costa rica87.69%>
japan43.85%>
puerto rico32.88%>
england21.92%>
ireland21.92%>
+View All
Port statistics
Total 8
Port NameTransactionsPerDetail
newark nj4644.23%>
newark, nj2120.19%>
boston1211.54%>
4601, new york/newark area, newark, nj98.65%>
jacksonville fl32.88%>
+View All
regeneron pharma inc. is united states Buyer,
and primarily engages in the import and export business of products such as pharmaceutical.
According to the 52wmb.com global trade database, as of 2026-03-03, the company has completed 104 international trades,
with its main trading regions covering costa rica,japan,puerto rico etc.
The core products include HS901831,HS300680 etc,
often transported via newark nj,port newark, nj, port boston etc,
and its main trading partners are nuova ompi s.r.l.,kuenhe nagel inc,ups freight.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on regeneron pharma inc. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.